その他の最近のニュースでは、Senseonics Holdingsは第4四半期の1株当たり損失が$0.02となり、予想の$0.03の損失を上回った。四半期の収益は$8.3百万で、予想の$7.79百万を上回り、前年同期比3.75%増となった。同社はまた、Eversense 365 CGMシステムの発売により、世界 ...

リスク開示書: 金融商品や仮想通貨の取引は投資金額を失う高いリスクがあります。仮想通貨の価格は非常にボラティリティーが高く、金融、規制、政治など、外的な要因に影響を受けることがあります。また信用取引はリスクが高いことを十分に理解して ...

Received FDA approval for Eversense® 365 Continuous Glucose Monitoring system and launched Eversense 365 with commercial ...

Senseonics (NYSE:SENS) shares ticked up after hours today on fourth-quarter results that came in ahead of the consensus ...

Senseonics and Ascensia integrate software between SweetSpot and Eversense 365, the world’s first and only One Year CGM system SweetSpot partners with endocrinology practices to provide virtual ...

Senseonics and Ascensia integrate software between SweetSpot and Eversense 365, the world’s first and only One Year CGM system SweetSpot partners with endocrinology practices to provide virtual CGM ...

Brian Hansen, President of CGM at Ascensia Diabetes Care and a Director of Senseonics, remarked, “Since joining Ascensia’s CGM division a year ago, I’ve watched Senseonics deliver on its ...

Highlights,FDA approval and US launch of Eversense® 365 CGM system drives 56% patient base growth.,Q4 2024 revenue reached $8 ...

Senseonics Holdings and Ascensia Diabetes Care announce the integration of SweetSpot with the Eversense 365 Continuous Glucose Monitoring (CGM) System in the U.S ...